Preferred Name

Tadalafil
Synonyms
Definitions

A carboline-based compound with vasodilatory activity. Tadalafil selectively inhibits the cyclic guanosine monophosphate (cGMP)-specific type 5 phosphodiesterase- (PDE-5)-mediated degradation of cGMP, which is found in the smooth muscle of the corpus cavernosa and corpus spongiosum of the penis. Inhibition of cGMP degradation by tadalafil results in prolonged muscle relaxation, vasodilation, and blood engorgement of the corpus cavernosa, and, so, prolonged penile erection.

ID

http://purl.obolibrary.org/obo/NCIT_C47743

Accepted_Therapeutic_Use_For

Benign Prostatic Hyperplasia

ALT_DEFINITION

A drug used to treat erectile dysfunction. It is also being studied in the treatment of sexual problems in patients treated with radiation or surgery for prostate cancer. Tadalafil blocks the action of a certain enzyme, which can result in increased blood flow to the penis, causing an erection. It is a type of cGMP phosphodiesterase type 5 (PDE5) inhibitor.

CAS_Registry

171596-29-5

Chemical_Formula

C22H19N3O4

code

C47743

Contributing_Source

CTRP

FDA

definition

A carboline-based compound with vasodilatory activity. Tadalafil selectively inhibits the cyclic guanosine monophosphate (cGMP)-specific type 5 phosphodiesterase- (PDE-5)-mediated degradation of cGMP, which is found in the smooth muscle of the corpus cavernosa and corpus spongiosum of the penis. Inhibition of cGMP degradation by tadalafil results in prolonged muscle relaxation, vasodilation, and blood engorgement of the corpus cavernosa, and, so, prolonged penile erection.

Display_Name

Tadalafil

FDA_UNII_Code

742SXX0ICT

in_subset

http://purl.obolibrary.org/obo/NCIT_C63923

http://purl.obolibrary.org/obo/NCIT_C176424

http://purl.obolibrary.org/obo/NCIT_C116977

http://purl.obolibrary.org/obo/NCIT_C116978

label

Tadalafil

Legacy Concept Name

Tadalafil

NCI_Drug_Dictionary_ID

462366

PDQ_Closed_Trial_Search_ID

462366

PDQ_Open_Trial_Search_ID

462366

Preferred_Name

Tadalafil

prefixIRI

NCIT:C47743

prefLabel

Tadalafil

Semantic_Type

Pharmacologic Substance

UMLS_CUI

C1176316

subClassOf

http://purl.obolibrary.org/obo/NCIT_C2127

Delete Subject Author Type Created
No notes to display
Create mapping

Delete Mapping To Ontology Source
http://sbmi.uth.tmc.edu/ontology/ochv#C1176316 OCHV LOOM
https://go.drugbank.com/drugs/DB00820 MDM LOOM
http://purl.bioontology.org/ontology/LNC/MTHU035872 LOINC LOOM
http://www.phoc.org.cn/pmo/class/PMO_00017696 PMAPP-PMO LOOM
http://purl.obolibrary.org/obo/CHEBI_71940 DRON LOOM
http://purl.obolibrary.org/obo/CHEBI_71940 PDRO LOOM
http://purl.obolibrary.org/obo/CHEBI_71940 FIDEO LOOM
http://purl.obolibrary.org/obo/CHEBI_71940 DINTO LOOM
http://purl.obolibrary.org/obo/CHEBI_71940 DDSS LOOM
http://purl.obolibrary.org/obo/CHEBI_71940 CHEBI LOOM
http://purl.bioontology.org/ontology/RXNORM/358263 RXNORM LOOM
http://sbmi.uth.tmc.edu/ontology/ochv#55830 OCHV LOOM
http://purl.obolibrary.org/obo/DRON_00018685 ODNAE LOOM
http://purl.bioontology.org/ontology/PDQ/CDR0000462366 PDQ LOOM
http://purl.bioontology.org/ontology/VANDF/4021415 VANDF LOOM
http://purl.obolibrary.org/obo/OMIT_0001297 OMIT LOOM
http://purl.bioontology.org/ontology/SNOMEDCT/407111005 SNOMEDCT LOOM
http://stirdf.jst.go.jp/id/200907003144367870 IOBC LOOM
https://bioportal.bioontology.org/ontologies/STMSO#Tadalafil STMSO LOOM
http://purl.bioontology.org/ontology/LNC/LP100055-5 LOINC LOOM
http://purl.bioontology.org/ontology/ATC/G04BE08 ATC LOOM
http://purl.jp/bio/4/id/200906093341709762 IOBC LOOM
http://evs.nci.nih.gov/ftp1/NDF-RT/NDF-RT.owl#N0000148829 ODAE LOOM
http://purl.bioontology.org/ontology/MESH/D000068581 MESH LOOM
http://www.drugbank.ca/drugs/DB00820 FTC LOOM
http://phenomebrowser.net/ontologies/mesh/mesh.owl#C429886 RH-MESH LOOM
http://purl.bioontology.org/ontology/NDFRT/N0000148829 NDFRT LOOM
http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl#C47743 NCIT LOOM
http://purl.bioontology.org/ontology/NDDF/009874 NDDF LOOM